Trial Profile
Performance of early 18F-florbetapir (eAV45) uptake as well as 18F-FDG PET as cerebral blood flow measures by comparison with the gold standards 15O-H2O PET
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 24 Oct 2017
Price :
$35
*
At a glance
- Drugs Florbetapir F 18 (Primary) ; Flortaucipir-F-18 (Primary)
- Indications Alzheimer's disease; Mild cognitive impairment
- Focus Diagnostic use
- 01 Sep 2017 Results published in the Journal of Nuclear Medicine
- 29 Aug 2017 New trial record
- 20 Jul 2017 Results presented at the Alzheimer's Association International Conference 2017